The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock

被引:75
作者
Martikainen, TJ [1 ]
Tenhunen, JJ [1 ]
Uusaro, A [1 ]
Ruokonen, E [1 ]
机构
[1] Kuopio Univ Hosp, Dept Anesthesiol & Intens Care, FIN-70211 Kuopio, Finland
关键词
D O I
10.1213/01.ANE.0000087039.60041.2E
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We compared the effects of vasopressin and norepinephrine on systemic and splanchnic circulation and metabolism in endotoxin shock in pigs. Twenty-one pigs were randomized to endotoxin shock (Escherichia coli endotoxin infusion) (n = 6), endotoxin and vasopressin (VASO, n = 6), enclotoxin and norepinephrine (NE; n = 6), and controls (n = 3). Endotoxin infusion was increased to induce hypotension, after which vasopressin or norepinephrine was started to keep systemic mean arterial blood pressure >70 mm Hg. Regional blood flows and arterial and regional lactate concentrations were measured. Tonometers with microdialysis capillaries were inserted into the stomach, jejunum, and colon. Systemic mean arterial blood pressure >70 mm Hg was achieved in the VASO and NE groups. Vasopressin decreased cardiac output, superior mesenteric artery, and portal vein blood flow, whereas hepatic arterial blood flow increased. Arterial lactate concentration increased from 2.0 mM (1.6-2.1 mM) to 4.7 mM (4.7-4.9 mM) (P = 0.007). Systemic and mesenteric oxygen delivery and consumption decreased and oxygen extraction increased in the VASO group. Vasopressin increased mucosal-arterial PCo2 gradients in all three locations, whereas luminal lactate release occurred only in the jejunum. Animals in the NE group remained stable. Vasopressin reversed hypotension but decreased systemic and gut blood flow. This was associated with hyperlactatemia, signs of visceral dysoxia, and jejunal luminal lactate release.
引用
收藏
页码:1756 / 1763
页数:8
相关论文
共 23 条
[1]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[2]   The epidemiology of the systemic inflammatory response [J].
Brun-Buisson, C .
INTENSIVE CARE MEDICINE, 2000, 26 (Suppl 1) :S64-S74
[3]   HEPATIC-ARTERY RESPONSE TO VASOPRESSIN [J].
BYNUM, TE ;
FARA, JW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 239 (05) :G378-G381
[4]   Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients [J].
Doig, CJ ;
Sutherland, LR ;
Sandham, JD ;
Fick, GH ;
Verhoef, M ;
Meddings, JB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) :444-451
[5]   Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs [J].
Hansen, EF ;
Strandberg, C ;
Hojgaard, L ;
Madsen, J ;
Henriksen, JH ;
Schroeder, TV ;
Becker, U ;
Bendtsen, F .
JOURNAL OF HEPATOLOGY, 1999, 30 (03) :503-510
[6]   The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series [J].
Holmes, CL ;
Walley, KR ;
Chittock, DR ;
Lehman, T ;
Russell, JA .
INTENSIVE CARE MEDICINE, 2001, 27 (08) :1416-1421
[7]   Splanchnic vasoregulation during mesenteric ischemia and reperfusion in pigs [J].
Jakob, SM ;
Tenhunen, JJ ;
Heino, A ;
Pradl, R ;
Alhava, E ;
Takala, J .
SHOCK, 2002, 18 (02) :142-147
[8]   THE EFFECT OF VASOPRESSIN ON HEPATIC-ARTERY FLOW IN THE RAT [J].
JENKINS, SA ;
MOONEY, B ;
DEVITT, P ;
TAYLOR, I ;
SHIELDS, R .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1984, 11 (05) :521-526
[9]   EFFECTS OF HISTAMINE, VASOPRESSIN, AND ANGIOTENSIN-II ON HEPATOSPLANCHNIC HEMODYNAMICS, LIVER-FUNCTION, AND HEPATIC-METABOLISM IN CATS [J].
KRARUP, N .
ACTA PHYSIOLOGICA SCANDINAVICA, 1975, 95 (03) :311-317
[10]  
Landry DW, 1997, CIRCULATION, V95, P1122